Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
NEW YORK, Oct. 25 /PRNewswire/ -- Standard & Poor's will make the following changes to the S&P SmallCap 600 index after the close of trading on October 31, 2007: -- Zep Inc. (NYSE:ZEPwi) will...
-- Strategic Acquisition Creates Premier Provider of Diabetes Care Services With 3.8 Million Patients Under Treatment FRANKLIN LAKES, N.J. and WAKEFIELD, Mass., Aug. 28 /PRNewswire/ -- Medco...
PolyMedica Corporation (NASDAQ: PLMD) announced today that it will participate in the Noble Financial Small Cap Conference/Micro Cap Symposium to be held August 20 ? 21, 2007...
PolyMedica Corporation (NASDAQ: PLMD): Fiscal 2008 First Quarter Highlights: Net revenues were $190.6 million, an increase of 22% over the prior year; Earnings...
PolyMedica Corporation (NASDAQ: PLMD) announced today that its Board of Directors has declared a regular cash dividend for its fiscal 2008 first quarter ended June 30, 2007, of...
PolyMedica Corporation (NASDAQ: PLMD) today announced that Thomas O. Pyle, Chairman of the Board of Directors for PolyMedica, passed away this morning, following a long illness...
Appointments aimed at building strength for new Hill-Rom Board when company separation is completed BATESVILLE, Ind., July 16 /PRNewswire-FirstCall/ -- Hillenbrand Industries, Inc. (NYSE:HB...
PolyMedica Corporation (NASDAQ:PLMD) today announced that it will provide an online Web simulcast of its fiscal 2008 first quarter conference call on Wednesday, August 1, 2007...
PolyMedica Corporation (NASDAQ: PLMD) announced today that it will participate in the Jefferies Healthcare Conference to be held June?26-28 in New York City. Patrick Ryan...
PolyMedica Corporation (NASDAQ: PLMD) today announced that its wholly owned subsidiary, Liberty Healthcare Group, Inc. (?Liberty?), the nation's largest mail order diabetes...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
